Get Task & Purpose in your inbox
The newest FDA-approved medication to treat severe depression, a nasal spray based on the anesthetic (and misused hallucinogenic party drug) ketamine, will soon be available to veterans treated within the Department of Veterans Affairs.
A pair of programs currently underway at a Veterans Affairs medical center in Cleveland aim to determine if a low-dose infusion of ketamine — the anesthetic that gained popularity for its street name ‘Special K’ in the 1960s and 70s — can help patients with treatment-resistant depression, and whether the drug can work as an emergency measure to help those at a high risk of suicide.
As I received my cap and gown from the book store clerk, I looked at the baby blue gown and dark blue tassel package in my hands and imagined walking on the grass alongside my classmates under the sun. I thought about what I will wear, how I will do my makeup, and how the graduation ceremony will end with happy tears, selfies, and family photos.
Dissatisfied with the quality of care and worried about reprisals from their command, service members are extensively seeking mental health care outside of the military, according to a new article in Military Medicine, an Oxford University Press journal.
Roughly half of all post-9/11 veterans who may need mental health care do not seek it through the Department of Veterans Affairs or in the private sector, according to a recent report by the National Academy of Sciences, Engineering, and Medicine.
While post-traumatic stress disorder has become a much-discussed affliction, a seemingly more prevalent problem is going largely overlooked: transition stress. Think of it as a clinical-sounding diagnosis for that sense of alienation many veterans feel after they leave the military.